Literature DB >> 19218341

High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors.

Laureen S Ojalvo1, William King, Dianne Cox, Jeffrey W Pollard.   

Abstract

Clinical and experimental evidence indicates that tumor-associated macrophages (TAMs) promote malignant progression. In breast cancer, TAMs enhance tumor angiogenesis, tumor cell invasion, matrix remodeling, and immune suppression against the tumor. In this study, we examined late-stage mammary tumors from a transgenic mouse model of breast cancer. We used flow cytometry under conditions that minimized gene expression changes to isolate a rigorously defined TAM population previously shown to be associated with invasive carcinoma cells. The gene expression signature of this population was compared with a similar population derived from spleens of non-tumor-bearing mice using high-density oligonucleotide arrays. Using stringent selection criteria, transcript abundance of 460 genes was shown to be differentially regulated between the two populations. Bioinformatic analyses of known functions of these genes indicated that formerly ascribed TAM functions, including suppression of immune activation and matrix remodeling, as well as multiple mediators of tumor angiogenesis, were elevated in TAMs. Further bioinformatic analyses confirmed that a pure and valid TAM gene expression signature in mouse tumors could be used to assess expression of TAMs in human breast cancer. The data derived from these more physiologically relevant autochthonous tumors compared with previous studies in tumor xenografts suggest tactics by which TAMs may regulate tumor angiogenesis and thus provide a basis for exploring other transcriptional mediators of TAM trophic functions within the tumor microenvironment.

Entities:  

Mesh:

Year:  2009        PMID: 19218341      PMCID: PMC2665764          DOI: 10.2353/ajpath.2009.080676

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  72 in total

1.  Influence of lymphocytes on the presence and organization of dendritic cell subsets in the spleen.

Authors:  M T Crowley; C R Reilly; D Lo
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

Review 2.  Macrophage receptors and immune recognition.

Authors:  P R Taylor; L Martinez-Pomares; M Stacey; H-H Lin; G D Brown; S Gordon
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

3.  Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop.

Authors:  Sumanta Goswami; Erik Sahai; Jeffrey B Wyckoff; Michael Cammer; Dianne Cox; Fiona J Pixley; E Richard Stanley; Jeffrey E Segall; John S Condeelis
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

4.  Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas.

Authors:  Tanja Xenia Pedersen; Caroline J Pennington; Kasper Almholt; Ib Jarle Christensen; Boye Schnack Nielsen; Dylan R Edwards; John Rømer; Keld Danø; Morten Johnsen
Journal:  Carcinogenesis       Date:  2005-03-10       Impact factor: 4.944

5.  Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

Authors:  T Ueno; M Toi; H Saji; M Muta; H Bando; K Kuroi; M Koike; H Inadera; K Matsushima
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

6.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Osteopontin expression in a group of lymph node negative breast cancer patients.

Authors:  A B Tuck; F P O'Malley; H Singhal; J F Harris; K S Tonkin; N Kerkvliet; Z Saad; G S Doig; A F Chambers
Journal:  Int J Cancer       Date:  1998-10-23       Impact factor: 7.396

8.  The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.

Authors:  H O Smith; P S Anderson; D Y Kuo; G L Goldberg; C L DeVictoria; C A Boocock; J G Jones; C D Runowicz; E R Stanley; J W Pollard
Journal:  Clin Cancer Res       Date:  1995-03       Impact factor: 12.531

9.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

Authors:  Sandeep S Dave; George Wright; Bruce Tan; Andreas Rosenwald; Randy D Gascoyne; Wing C Chan; Richard I Fisher; Rita M Braziel; Lisa M Rimsza; Thomas M Grogan; Thomas P Miller; Michael LeBlanc; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Joseph M Connors; Peter M Lansdorp; Qin Ouyang; T Andrew Lister; Andrew J Davies; Andrew J Norton; H Konrad Muller-Hermelink; German Ott; Elias Campo; Emilio Montserrat; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Liming Yang; John Powell; Hong Zhao; Neta Goldschmidt; Michael Chiorazzi; Louis M Staudt
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245

10.  Postnatal mammary gland development requires macrophages and eosinophils.

Authors:  V Gouon-Evans; M E Rothenberg; J W Pollard
Journal:  Development       Date:  2000-06       Impact factor: 6.868

View more
  98 in total

1.  Tumor-associated macrophages in stage IIIA pN2 non-small cell lung cancer after neoadjuvant chemotherapy and surgery.

Authors:  Po-Hao Feng; Chih-Teng Yu; Chin-Yang Wu; Meng-Jung Lee; Wei-Hwa Lee; Liang-Shun Wang; Shu-Min Lin; Jen-Fen Fu; Kang-Yun Lee; Tzung-Hai Yen
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

Review 2.  Macrophage polarization and plasticity in health and disease.

Authors:  Subhra K Biswas; Manesh Chittezhath; Irina N Shalova; Jyue-Yuan Lim
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 3.  Macrophage diversity enhances tumor progression and metastasis.

Authors:  Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

Review 4.  Leukocytes in mammary development and cancer.

Authors:  Lisa M Coussens; Jeffrey W Pollard
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 5.  Differential macrophage programming in the tumor microenvironment.

Authors:  Brian Ruffell; Nesrine I Affara; Lisa M Coussens
Journal:  Trends Immunol       Date:  2012-01-23       Impact factor: 16.687

6.  Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages.

Authors:  Delisha A Stewart; Yinmeng Yang; Liza Makowski; Melissa A Troester
Journal:  Mol Cancer Res       Date:  2012-04-24       Impact factor: 5.852

7.  Many Roles of CCL20: Emphasis on Breast Cancer.

Authors:  Kingsley O Osuala; Bonnie F Sloane
Journal:  Postdoc J       Date:  2014-03

8.  Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors.

Authors:  Laureen S Ojalvo; Charles A Whittaker; John S Condeelis; Jeffrey W Pollard
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

9.  The tumor microenvironment shapes lineage, transcriptional, and functional diversity of infiltrating myeloid cells.

Authors:  Kutlu G Elpek; Viviana Cremasco; Hua Shen; Christopher J Harvey; Kai W Wucherpfennig; Daniel R Goldstein; Paul A Monach; Shannon J Turley
Journal:  Cancer Immunol Res       Date:  2014-03-31       Impact factor: 11.151

10.  Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs).

Authors:  Weiwei Yang; Yan Lu; Yichen Xu; Lizhi Xu; Wei Zheng; Yuanyuan Wu; Long Li; Pingping Shen
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.